Genetic testing company 23andMe has raised $28 million in Series B according to a company regulatory filing. The company raised $11 million of the Series B round of funding back in May and raised the rest of it recently. The company initially planned to raised $24.26 million. 23andMe was founded by Anne Wojcicki and Linda Avey. Avey recently quit the company but remained on the board of directors. 23andMe’s Series A round of funding was provided by Google, Genentech, Mohr Davidow Ventures (MDV), and New Enterprise Associates. MDV sold their stake back to 23andMe and invested in another rival company called Navigenics.